| Parent Drug Name | Name of Impurity | Catalogue No. | |
|---|---|---|---|
| Difluoroprednisolone | Dimethoxy difluoroprednisolone | VE008760 | View |
| Difluoroprednisolone | 17α, 21-Dideoxy-6α, 9α-Difluoroprednisolone | VE008763 | View CAS 167997-12-8 |
| Difluoroprednisolone | 6α, 9α-Difluoroprednisolone 21-Acetate | VE008769 | View CAS 52-70-0 |
[rfq_list]
| Catalogue No. | VE008763 |
| CAS No. | 167997-12-8 |
| Molecular Formula | C20H24F2O4 |
| Molecular Weight | 366.40 g/mol |
| Parent drug | Difluoroprednisolone |
| IUPAC Name | (6S, 8S, 9R, 10S, 11S, 13S, 14S, 17S)-6, 9-difluoro-11-hydroxy-10, 13-dimethyl-3-oxo-6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17-dodecahydro-3H-cyclopenta[a]phenanthrene-17-carboxylic acid |
| Synonyms | N/A |
| References | https://www.facebook.com/Drugscom. “FDA Approves Durezol.” Drugs.com, Drugs.com, 2022, http://www.drugs.com/newdrugs/sirion-therapeutics-announces-fda-approval-durezol-treatmentof-postoperative-ocular-inflammation-1031.html. |
| Status | In-stock |
| ListName | 17α, 21-Dideoxy-6α, 9α-Difluoroprednisolone |
| Exclusively Supplied by Veeprho | Exclusively Supplied by Veeprho |
"*" indicates required fields
